China Resources Pharmaceutical Group Balance Sheet Health
Financial Health criteria checks 6/6
China Resources Pharmaceutical Group has a total shareholder equity of CN¥93.0B and total debt of CN¥60.9B, which brings its debt-to-equity ratio to 65.5%. Its total assets and total liabilities are CN¥246.8B and CN¥153.8B respectively. China Resources Pharmaceutical Group's EBIT is CN¥11.0B making its interest coverage ratio 6.2. It has cash and short-term investments of CN¥32.2B.
Key information
65.5%
Debt to equity ratio
CN¥60.85b
Debt
Interest coverage ratio | 6.2x |
Cash | CN¥32.23b |
Equity | CN¥92.97b |
Total liabilities | CN¥153.80b |
Total assets | CN¥246.77b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 640's short term assets (CN¥178.6B) exceed its short term liabilities (CN¥134.2B).
Long Term Liabilities: 640's short term assets (CN¥178.6B) exceed its long term liabilities (CN¥19.6B).
Debt to Equity History and Analysis
Debt Level: 640's net debt to equity ratio (30.8%) is considered satisfactory.
Reducing Debt: 640's debt to equity ratio has reduced from 89.2% to 65.5% over the past 5 years.
Debt Coverage: 640's debt is well covered by operating cash flow (25.6%).
Interest Coverage: 640's interest payments on its debt are well covered by EBIT (6.2x coverage).